Determination of the Lowest, Safe and Effective Dose of Proellex
Clinical trial NCT01187043 · COMPLETED
Trial details
- NCT number
- NCT01187043
- Sponsor
- Repros Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2012-03-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.